What companies are IBRX's competitors?

ImmunityBio, Inc. (IBRX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does IBRX compare to its peers?

The peer comparison table on this page shows ImmunityBio, Inc. (IBRX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does IBRX operate in?

ImmunityBio, Inc. (IBRX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

IBRX

ImmunityBio, Inc.

NASDAQ·Biotechnology · Healthcare

$8.22$0.09−1.08%

Market cap$8.71B·Market closed·Oct 23 4:00 PM EDT

Frequently Asked Questions About IBRX

What companies are IBRX's competitors?: ImmunityBio, Inc. (IBRX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does IBRX compare to its peers?: The peer comparison table on this page shows ImmunityBio, Inc. (IBRX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does IBRX operate in?: ImmunityBio, Inc. (IBRX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

IBRX

ImmunityBio, Inc.

NASDAQ·Biotechnology · Healthcare

$8.22$0.09−1.08%

Market cap$8.71B·Market closed·Oct 23 4:00 PM EDT

Peers

Sort:


MRNAMRNAModerna, Inc.	Moderna, Inc.	$200.10	$79.9B
BNTXBNTXBioNTech SE	BioNTech SE	$88.12	$22.1B
IOVAIOVAIovance Biotherapeutics, Inc.	Iovance Biotherapeutics, Inc.	$14.09	$6.4B
LEGNLEGNLegend Biotech Corporation	Legend Biotech Corporation	$19.27	$3.6B
VIRVIRVir Biotechnology, Inc.	Vir Biotechnology, Inc.	$10.57	$1.8B
IMCRIMCRImmunocore Holdings plc	Immunocore Holdings plc	$30.98	$1.6B
IMTXIMTXImmatics N.V.	Immatics N.V.	$7.31	$1.1B
ALLOALLOAllogene Therapeutics, Inc.	Allogene Therapeutics, Inc.	$1.25	$431.9M
NKTXNKTXNkarta, Inc.	Nkarta, Inc.	$1.79	$128.2M
ATRAATRAAtara Biotherapeutics, Inc.	Atara Biotherapeutics, Inc.	$8.59	$86.2M

Frequently Asked Questions About IBRX

What companies are IBRX's competitors?: ImmunityBio, Inc. (IBRX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does IBRX compare to its peers?: The peer comparison table on this page shows ImmunityBio, Inc. (IBRX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does IBRX operate in?: ImmunityBio, Inc. (IBRX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.